{"id":"W1969320029","doi":"10.1007/s00280-010-1530-7","title":"A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients","year":2010,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Charles-Le Moyne; Jewish General Hospital","funders":"Novartis Pharmaceuticals Canada","keywords":"Chlorambucil; Imatinib; Medicine; Fludarabine; Imatinib mesylate; Chronic lymphocytic leukemia; Tyrosine-kinase inhibitor; Pharmacology; Internal medicine; Chemotherapy; Leukemia; Gastroenterology; Oncology; Cancer; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002619245,0.0002020076,0.0005132214,0.0002527038,0.00002969027,0.000007483539,0.0001117856,0.0001311536,0.000449025],"category_scores_gemma":[0.00001467958,0.0001639806,0.00002578564,0.0004880916,0.0001866458,0.00008653557,0.00002721662,0.0003571628,0.000001763241],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01565457,"about_ca_system_score_gemma":0.00720195,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003286286,"about_ca_topic_score_gemma":0.00156452,"domain_scores_codex":[0.9985341,0.00008649789,0.0003987347,0.000369873,0.0002299395,0.0003808457],"domain_scores_gemma":[0.9993241,0.00009722581,0.0001444662,0.0001887788,0.0001267136,0.0001186462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.05628975,0.01758467,0.2796934,0.002704553,0.001129633,0.0005985284,0.03010884,0.0009466295,0.3539368,0.00003176192,0.0006601376,0.2563153],"study_design_scores_gemma":[0.7494672,0.01330997,0.02530732,0.0002397589,0.0001723238,0.00004325757,0.0002054464,0.06675045,0.1435139,0.00002588942,0.0006330197,0.0003314131],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970245,0.0004307562,0.000001873615,0.00007761038,0.0001126393,0.00219073,0.000005362203,0.00002278716,0.0001336927],"genre_scores_gemma":[0.9984285,0.0007186971,0.00001955041,0.0002325919,0.00006087399,0.000381125,0.00001646018,0.00003333136,0.0001088278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6931775,"threshold_uncertainty_score":0.9984263,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0152859007704815,"score_gpt":0.3521121000178381,"score_spread":0.3368261992473566,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}